Vancouver, British Columbia--(Newsfile Corp. - May 23, 2018) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)
(the "Company" or "PreveCeutical"), announces that, further to shareholder approval of a forward stock split (the
"Stock Split") of the Company's issued and outstanding common shares (each, a "Share") on the basis of five new
Shares for each one existing Share (see news release dated May 17, 2018), the Company's Shares have commenced trading today on
the Canadian Securities Exchange on an "ex-distribution" basis.
The record date for the Stock Split has been set at May 24, 2018. Shareholders of the Company do not need to take any action
with respect to the Stock Split.
About PreveCeutical
PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilizing
organic and nature identical products.
PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs,
including: dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature
Identical™ peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly
addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from
concussions (mild traumatic brain injury).
PreveCeutical sells CELLB9®, an Immune System Booster. CELLB9® is an oral solution containing polarized
and potentiated essential minerals extracted from a novel peptide obtained from Caribbean Blue Scorpion venom. This product is
available on the Company's website.
For more information about PreveCeutical, please visit www.PreveCeutical.com, follow
us on Twitter: http://twitter.com/PreveCeuticals and Facebook: www.facebook.com/PreveCeutical.
On Behalf of the Board of Directors
"Stephen Van Deventer"
Chairman, CEO and President
For further information, please contact:
Deanna Kress
Director of Corporate Communications & Investor Relations
+1-778-999-6063
deanna@PreveCeutical.com
Forward-Looking Statements:
This news release contains forward-looking statements and forward-looking information (collectively, "forward-looking
statements") within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private
Securities Litigation Reform Act of 1995. All statements in this news release that are not purely historical are
forward-looking statements and include any statements regarding beliefs, plans, expectations and orientations regarding the future
including the Company's anticipated business plans and its prospect of success in executing its proposed plans. Often, but not
always, forward-looking statements can be identified by words such as "plans", "expects", "may", "intends", "anticipates",
"believes", "proposes" or variations of such words including negative variations thereof and phrases that refer to certain actions,
events or results that may, could, would, might or will occur or be taken or achieved. Actual results could differ from those
projected in any forward-looking statements due to numerous factors including the inability of the Company to execute its proposed
business plans and obtain the financing required to carry out its planned future activities. Other factors such as general
economic, market or business conditions or changes in laws, regulations and policies affecting the biotechnology or pharmaceutical
industry, may also adversely affect the future results or performance of the Company. These forward-looking statements are made as
of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the
forward-looking statements or to update the reasons why actual results could differ from those projected in these forward-looking
statements. Although the Company believes that the statements, beliefs, plans, expectations, and intentions contained in this news
release are reasonable, there can be no assurance that those statements, beliefs, plans, expectations, or intentions will prove to
be accurate. Readers should consider all of the information set forth herein and should also refer to other periodic reports
provided by the Company from time-to-time. These reports and the Company's filings are available at www.sedar.com.
Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are
cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such
statements.
